Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF THE FULL ECTODOMAIN OF HUMAN GP130: NEW INSIGHTS INTO THE MOLECULAR ASSEMBLY OF RECEPTOR COMPLEXES
 
Authors :  Y. Xu, T. P. J. Garrett, J. G. Zhang
Date :  21 Dec 09  (Deposition) - 19 May 10  (Release) - 05 Apr 17  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  3.60
Chains :  Asym./Biol. Unit :  A
Keywords :  Ig-Like, Fniii, Cell Membrane, Disulfide Bond, Glycoprotein, Immunoglobulin Domain, Membrane, Phosphoprotein, Receptor, Secreted, Transmembrane, Immune System (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  Y. Xu, N. J. Kershaw, C. S. Luo, P. Soo, M. J. Pocock, P. E. Czabotar, D. J. Hilton, N. A. Nicola, T. P. Garrett, J. G. Zhang
Crystal Structure Of The Entire Ectodomain Of Gp130: Insights Into The Molecular Assembly Of The Tall Cytokine Receptor Complexes.
J. Biol. Chem. V. 285 21214 2010
PubMed-ID: 20489211  |  Reference-DOI: 10.1074/JBC.C110.129502

(-) Compounds

Molecule 1 - INTERLEUKIN-6 RECEPTOR SUBUNIT BETA
    ChainsA
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF21
    Expression System CommonFALL ARMYWORM
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    FragmentECOTODOMAIN
    GeneIL6ST
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymIL-6R-BETA, INTERLEUKIN-6 SIGNAL TRANSDUCER, MEMBRANE GLYCOPROTEIN 130, GP130, CDW130, ONCOSTATIN-M RECEPTOR SUBUNIT ALPHA

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (5, 22)

Asymmetric/Biological Unit (5, 22)
No.NameCountTypeFull Name
1BMA5Ligand/IonBETA-D-MANNOSE
2FUC1Ligand/IonALPHA-L-FUCOSE
3NAG12Ligand/IonN-ACETYL-D-GLUCOSAMINE
4NDG1Ligand/Ion2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
5SO43Ligand/IonSULFATE ION

(-) Sites  (22, 22)

Asymmetric Unit (22, 22)
No.NameEvidenceResiduesDescription
01AC1SOFTWAREARG A:121BINDING SITE FOR RESIDUE SO4 A 1
02AC2SOFTWAREARG A:276BINDING SITE FOR RESIDUE SO4 A 591
03AC3SOFTWAREARG A:373BINDING SITE FOR RESIDUE SO4 A 592
04AC4SOFTWAREHIS A:204 , ASN A:205 , NAG A:594BINDING SITE FOR RESIDUE NAG A 593
05AC5SOFTWARENAG A:593BINDING SITE FOR RESIDUE NAG A 594
06AC6SOFTWAREASN A:135 , NAG A:596BINDING SITE FOR RESIDUE NDG A 595
07AC7SOFTWARENDG A:595 , BMA A:597BINDING SITE FOR RESIDUE NAG A 596
08AC8SOFTWARENAG A:596 , BMA A:598BINDING SITE FOR RESIDUE BMA A 597
09AC9SOFTWAREBMA A:597BINDING SITE FOR RESIDUE BMA A 598
10BC1SOFTWAREASN A:61 , THR A:63 , NAG A:600BINDING SITE FOR RESIDUE NAG A 599
11BC2SOFTWARENAG A:599BINDING SITE FOR RESIDUE NAG A 600
12BC3SOFTWARELEU A:342 , ASN A:361 , NAG A:602BINDING SITE FOR RESIDUE NAG A 601
13BC4SOFTWAREILE A:341 , NAG A:601 , BMA A:603BINDING SITE FOR RESIDUE NAG A 602
14BC5SOFTWARENAG A:602BINDING SITE FOR RESIDUE BMA A 603
15BC6SOFTWAREARG A:530 , ASN A:531 , ASP A:575 , NAG A:607BINDING SITE FOR RESIDUE NAG A 606
16BC7SOFTWAREASP A:575 , GLU A:576 , NAG A:606 , BMA A:608BINDING SITE FOR RESIDUE NAG A 607
17BC8SOFTWARENAG A:607 , BMA A:609BINDING SITE FOR RESIDUE BMA A 608
18BC9SOFTWAREBMA A:608BINDING SITE FOR RESIDUE BMA A 609
19CC1SOFTWAREGLU A:345 , ASN A:357 , FUC A:605BINDING SITE FOR RESIDUE NAG A 604
20CC2SOFTWARENAG A:604BINDING SITE FOR RESIDUE FUC A 605
21CC3SOFTWAREASN A:21 , NAG A:611BINDING SITE FOR RESIDUE NAG A 610
22CC4SOFTWARENAG A:610BINDING SITE FOR RESIDUE NAG A 611

(-) SS Bonds  (5, 5)

Asymmetric/Biological Unit
No.Residues
1A:6 -A:32
2A:26 -A:81
3A:112 -A:122
4A:150 -A:160
5A:436 -A:444

(-) Cis Peptide Bonds  (3, 3)

Asymmetric/Biological Unit
No.Residues
1Ser A:10 -Pro A:11
2Gly A:385 -Lys A:386
3Lys A:413 -Asp A:414

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (7, 7)

Asymmetric/Biological Unit (7, 7)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_047783G148RIL6RB_HUMANPolymorphism2228044AG126R
2UniProtVAR_074654A200GIL6RB_HUMANUnclassified199905033AA178G
3UniProtVAR_047784L397VIL6RB_HUMANPolymorphism2228043AL375V
4UniProtVAR_036165T415IIL6RB_HUMANUnclassified  ---AT393I
5CancerSNPVAR_IL6RB_HUMAN_CCDS3971_1_01 *T415IIL6RB_HUMANDisease (Colorectal cancer)  ---AT393I
6UniProtVAR_047785I454TIL6RB_HUMANPolymorphism2228046AI432T
7UniProtVAR_047786V499IIL6RB_HUMANPolymorphism34417936AV477I
   * ID not provided by source

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 5)

Asymmetric/Biological Unit (2, 5)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1FN3PS50853 Fibronectin type-III domain profile.IL6RB_HUMAN224-324
518-613
426-517
329-424
  4A:202-302
A:496-590
A:404-495
A:307-402
2HEMATOPO_REC_L_F2PS01353 Long hematopoietin receptor, gp130 family signature.IL6RB_HUMAN404-457  1A:382-435

(-) Exons   (11, 11)

Asymmetric/Biological Unit (11, 11)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003812981aENSE00001488125chr5:55290772-55290612161IL6RB_HUMAN-00--
1.2aENST000003812982aENSE00001488122chr5:55278639-5527855288IL6RB_HUMAN-00--
1.3cENST000003812983cENSE00002172585chr5:55272121-5527204379IL6RB_HUMAN1-22220--
1.4bENST000003812984bENSE00000914155chr5:55265683-55265378306IL6RB_HUMAN22-1241031A:2-102 (gaps)101
1.5ENST000003812985ENSE00000914153chr5:55264224-55264104121IL6RB_HUMAN124-164411A:102-14241
1.6bENST000003812986bENSE00000914150chr5:55260140-55259974167IL6RB_HUMAN164-220571A:142-19857
1.7ENST000003812987ENSE00000914147chr5:55259334-55259180155IL6RB_HUMAN220-271521A:198-24952
1.8aENST000003812988aENSE00001006585chr5:55256389-55256230160IL6RB_HUMAN272-325541A:250-30354
1.10ENST0000038129810ENSE00000914138chr5:55253119-5525303783IL6RB_HUMAN325-352281A:303-33028
1.11aENST0000038129811aENSE00001745568chr5:55252063-55251853211IL6RB_HUMAN353-423711A:331-40171
1.12ENST0000038129812ENSE00001685217chr5:55250820-55250638183IL6RB_HUMAN423-484621A:401-46262
1.13ENST0000038129813ENSE00001781723chr5:55248179-55248078102IL6RB_HUMAN484-518351A:462-49635
1.14ENST0000038129814ENSE00001750732chr5:55247903-55247757147IL6RB_HUMAN518-567501A:496-54550
1.15aENST0000038129815aENSE00001667221chr5:55247432-55247292141IL6RB_HUMAN567-614481A:545-59046
1.17dENST0000038129817dENSE00001743622chr5:55243417-5524332197IL6RB_HUMAN614-646330--
1.18ENST0000038129818ENSE00001611906chr5:55238579-5523849882IL6RB_HUMAN646-673280--
1.19eENST0000038129819eENSE00001488109chr5:55237647-552309236725IL6RB_HUMAN674-9182450--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:585
 aligned with IL6RB_HUMAN | P40189 from UniProtKB/Swiss-Prot  Length:918

    Alignment length:589
                                    33        43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453       463       473       483       493       503       513       523       533       543       553       563       573       583       593       603         
          IL6RB_HUMAN    24 LLDPCGYISPESPVVQLHSNFTAVCVLKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIINRTASSVTFTDIASLNIQLTCNILTFGQLEQNVYGITIISGLPPEKPKNLSCIVNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGITYEDRPSKAPSFWYKIDPSHTQGYRTVQLVWKTLPPFEANGKILDYEVTLTRWKSHLQNYTVNATKLTVNLTNDRYLATLTVRNLVGKSDAAVLTIPACDFQATHPVMDLKAFPKDNMLWVEWTTPRESVKKYILEWCVLSDKAPCITDWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIKAYLKQAPPSKGPTVRTKKVGKNEAVLEWDQLPVDVQNGFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRMAAYTDEGGKDGPEFTFTTPK 612
               SCOP domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) Lep_receptor_Ig-3l5hA04 A :2-92                                                            -------- ----IL6Ra-bind-3l5hA01 A:106-195                                                              ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn3-3l5hA02 A:496-583                                                                   ------- Pfam domains (1)
           Pfam domains (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------fn3-3l5hA03 A:496-583                                                                   ------- Pfam domains (2)
         Sec.struct. author .........................-.........................hhhhh.........................-......-..........-......eeeeeeee....eeeeee........eeeee...........ee....................eee.eeeee.........eeehhhh.ee.......eee........eeee...hhhhhh..eeeeeeeee...................eeee........eeeeeeeee............................eeee...........eeeee.............eeeeee.................ee........eeeeee...........................eeee....eeee.............eeeee.......eee........eee.........eeeeee..ee..ee...eeeeee.............ee.......ee.....hhhhhh..eeeeee...........eee.................ee..eeeee..eeee....ee.... Sec.struct. author
             SAPs(SNPs) (1) ----------------------------------------------------------------------------------------------------------------------------R---------------------------------------------------G----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------V-----------------I--------------------------------------T--------------------------------------------I----------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------I----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
                PROSITE (1) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FN3  PDB: A:202-302 UniProt: 224-324                                                                 ----FN3  PDB: A:307-402 UniProt: 329-424                                                            -FN3  PDB: A:404-495 UniProt: 426-517                                                        FN3  PDB: A:496-590 UniProt: 518-613                                                            PROSITE (1)
                PROSITE (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------HEMATOPO_REC_L_F2  PDB: A:382-435 UniProt: 404-457    ----------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.4b  PDB: A:2-102 (gaps) UniProt: 22-124 [INCOMPLETE]                                          ---------------------------------------Exon 1.6b  PDB: A:142-198 UniProt: 164-220               --------------------------------------------------------------------------------------------------------Exon 1.10  PDB: A:303-330   Exon 1.11a  PDB: A:331-401 UniProt: 353-423                            ------------------------------------------------------------Exon 1.13  PDB: A:462-496          ------------------------------------------------Exon 1.15a  PDB: A:545-590 UniProt: 567-614    Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------Exon 1.5  PDB: A:102-142 UniProt: 124-164-------------------------------------------------------Exon 1.7  PDB: A:198-249 UniProt: 220-271           Exon 1.8a  PDB: A:250-303 UniProt: 272-325            -------------------------------------------------------------------------------------------------Exon 1.12  PDB: A:401-462 UniProt: 423-484                    ---------------------------------Exon 1.14  PDB: A:496-545 UniProt: 518-567        --------------------------------------------- Transcript 1 (2)
                 3l5h A   2 LLDPCGYISPESPVVQLHSNFTAVC-LKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIINRTASSVTFTDIASLNIQLTCN-LTFGQL-QNVYGITIIS-LPPEKPKNLSCIVNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGITYEDRPSKAPSFWYKIDPSHTQGYRTVQLVWKTLPPFEANGKILDYEVTLTRWKSHLQNYTVNATKLTVNLTNDRYLATLTVRNLVGKSDAAVLTIPACDFQATHPVMDLKAFPKDNMLWVEWTTPRESVKKYILEWCVLSDKAPCITDWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIKAYLKQAPPSKGPTVRTKKVGKNEAVLEWDQLPVDVQNGFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRMAAYTDEGGKDGPEFTFTTPK 590
                                    11        21    | | 31        41        51        61        71        81| |    |91        |-|      111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491       501       511       521       531       541       551       561       571       581         
                                                   26 |                                                    82 |   89 |      100 |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                     28                                                      84     91        102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (0, 0)

(no "SCOP Domain" information available for 3L5H)

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 3L5H)

(-) Pfam Domains  (3, 4)

Asymmetric/Biological Unit
(-)
Clan: E-set (290)
(-)
Clan: Ig (577)

(-) Gene Ontology  (49, 49)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (IL6RB_HUMAN | P40189)
molecular function
    GO:0004897    ciliary neurotrophic factor receptor activity    Combining with ciliary neurotrophic factor (CNTF) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0005127    ciliary neurotrophic factor receptor binding    Interacting selectively and non-covalently with the ciliary neurotrophic factor receptor.
    GO:0004896    cytokine receptor activity    Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0019838    growth factor binding    Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
    GO:0019970    interleukin-11 binding    Interacting selectively and non-covalently with interleukin-11.
    GO:0004921    interleukin-11 receptor activity    Combining with interleukin-11 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0045509    interleukin-27 receptor activity    Combining with interleukin-27 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0019981    interleukin-6 binding    Interacting selectively and non-covalently with interleukin-6.
    GO:0004915    interleukin-6 receptor activity    Combining with interleukin-6 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0005138    interleukin-6 receptor binding    Interacting selectively and non-covalently with the interleukin-6 receptor.
    GO:0004923    leukemia inhibitory factor receptor activity    Combining with leukemia inhibitory factor (LIF) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0004924    oncostatin-M receptor activity    Combining with oncostatin-M and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
    GO:0070120    ciliary neurotrophic factor-mediated signaling pathway    A series of molecular signals initiated by the binding of a ciliary neurotrophic factor (CNTF) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0019221    cytokine-mediated signaling pathway    A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0005977    glycogen metabolic process    The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha-(1->4) glycosidic linkage, joined together by alpha-(1->6) glycosidic linkages.
    GO:0038154    interleukin-11-mediated signaling pathway    A series of molecular signals initiated by the binding of interleukin-11 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0070106    interleukin-27-mediated signaling pathway    A series of molecular signals initiated by the binding of interleukin-27 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0070102    interleukin-6-mediated signaling pathway    A series of molecular signals initiated by the binding of interleukin-6 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0048861    leukemia inhibitory factor signaling pathway    Any series of molecular signals initiated by the binding of leukemia inhibitory factor to a receptor on the surface of the target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0070104    negative regulation of interleukin-6-mediated signaling pathway    Any process that decreases the rate, frequency or extent of the series of molecular events generated as a consequence of interleukin-6 binding to a cell surface receptor.
    GO:0038165    oncostatin-M-mediated signaling pathway    A series of molecular signals initiated by the binding of oncostatin-M (OSM) to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. OSM can signal via at least two different receptors (a specific receptor and a LIF receptor) to activate different downstream signal transduction pathways.
    GO:0042102    positive regulation of T cell proliferation    Any process that activates or increases the rate or extent of T cell proliferation.
    GO:0002675    positive regulation of acute inflammatory response    Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response.
    GO:0002821    positive regulation of adaptive immune response    Any process that activates or increases the frequency, rate, or extent of an adaptive immune response.
    GO:0048711    positive regulation of astrocyte differentiation    Any process that activates or increases the frequency, rate or extent of astrocyte differentiation.
    GO:0010613    positive regulation of cardiac muscle hypertrophy    Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0045669    positive regulation of osteoblast differentiation    Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
    GO:0010575    positive regulation of vascular endothelial growth factor production    Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
    GO:0008593    regulation of Notch signaling pathway    Any process that modulates the frequency, rate or extent of the Notch signaling pathway.
    GO:0034097    response to cytokine    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0016032    viral process    A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
    GO:0044297    cell body    The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections.
    GO:0070110    ciliary neurotrophic factor receptor complex    A protein complex that acts as a receptor for the cytokine ciliary neurotrophic factor (CNTF). In humans the receptor complex is a hexamer composed of two molecules each of CNTF and CNTFR and one molecule each of gp130 and LIFR.
    GO:0030425    dendrite    A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005896    interleukin-6 receptor complex    A hexameric protein complex consisting of two molecules each of interleukin-6, interleukin-6 receptor alpha chain, and gp-130.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0043025    neuronal cell body    The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
    GO:0005900    oncostatin-M receptor complex    A heterodimeric receptor for the cytokine oncostatin-M (OSM). In humans the receptor complex is made up of the gene products gp130 and OSMR-beta.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    BMA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NDG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
    AC9  [ RasMol ]  +environment [ RasMol ]
    BC1  [ RasMol ]  +environment [ RasMol ]
    BC2  [ RasMol ]  +environment [ RasMol ]
    BC3  [ RasMol ]  +environment [ RasMol ]
    BC4  [ RasMol ]  +environment [ RasMol ]
    BC5  [ RasMol ]  +environment [ RasMol ]
    BC6  [ RasMol ]  +environment [ RasMol ]
    BC7  [ RasMol ]  +environment [ RasMol ]
    BC8  [ RasMol ]  +environment [ RasMol ]
    BC9  [ RasMol ]  +environment [ RasMol ]
    CC1  [ RasMol ]  +environment [ RasMol ]
    CC2  [ RasMol ]  +environment [ RasMol ]
    CC3  [ RasMol ]  +environment [ RasMol ]
    CC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Gly A:385 - Lys A:386   [ RasMol ]  
    Lys A:413 - Asp A:414   [ RasMol ]  
    Ser A:10 - Pro A:11   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3l5h
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  IL6RB_HUMAN | P40189
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  IL6RB_HUMAN | P40189
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        IL6RB_HUMAN | P401891bj8 1bqu 1i1r 1n2q 1p9m 1pvh 3l5i 3l5j

(-) Related Entries Specified in the PDB File

3l5i 3l5j